CLINICAL_TRIALS trial_result · 2019-03-27

Clinical Trial Update: A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - FORWARD-5 Study [Phase 3]

A Phase 3 clinical trial update for ALKS 5461 in treatment of Major Depressive Disorder has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Alkermes, Inc. | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2019-03-27